Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents. [electronic resource]
Producer: 20151006Description: 902-8 p. digitalISSN:- 1349-7006
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Drug Synergism
- Fanconi Anemia Complementation Group D2 Protein -- metabolism
- Humans
- Lung Neoplasms
- Pentacyclic Triterpenes
- Proteasome Endopeptidase Complex -- metabolism
- Protein Stability
- Proteolysis
- Triterpenes -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.